Food and Drug Administration (FDA) is hosting the webinar, FDA Drug Topics: An Update on Transmucosal Buprenorphine and Dental Caries, on December 10, 2024, at noon CST. The webinar will focus on regulatory actions regarding transmucosal products and dental caries, as well as discuss the national opioid crisis, opioid use disorder, and available treatments. This webinar is available for one continuing pharmacy education contact hour after both attending and completing all required activity evaluations in the FDA Continuing Education Portal within 14 days after the webinar.
